Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 7150959, 10 pages
http://dx.doi.org/10.1155/2016/7150959
Review Article

The Role of H. pylori CagA in Regulating Hormones of Functional Dyspepsia Patients

1Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province 646000, China
2School of Foreign Languages, Southwest Medical University, Luzhou, Sichuan Province 646000, China

Received 9 July 2016; Accepted 28 August 2016

Academic Editor: Branka Filipović

Copyright © 2016 Wang-Ping Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. J. Talley and A. C. Ford, “Functional dyspepsia,” The New England Journal of Medicine, vol. 373, no. 19, pp. 1853–1863, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. R. S. Choung and N. J. Talley, “Novel mechanisms in functional dyspepsia,” World Journal of Gastroenterology, vol. 12, no. 5, pp. 673–677, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Turkkan, I. Uslan, G. Acarturk et al., “Does Helicobacter pylori-induced inflammation of gastric mucosa determine the severity of symptoms in functional dyspepsia?” Journal of Gastroenterology, vol. 44, no. 1, pp. 66–70, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. R. J. L. F. Loffeld, B. F. M. Werdmuller, J. G. Kusters, and E. J. Kuipers, “Functional dyspepsia is associated with cagA-positive Helicobacter pylori strains,” Scandinavian Journal of Gastroenterology, vol. 36, no. 4, pp. 351–355, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. N. A. Koloski, M. Jones, J. Kalantar, M. Weltman, J. Zaguirre, and N. J. Talley, “The brain—gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study,” Gut, vol. 61, no. 9, pp. 1284–1290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S.-H. Kuo, K.-H. Yeh, L.-T. Chen et al., “Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma,” American Journal of Surgical Pathology, vol. 39, no. 6, pp. 761–766, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Stein, P. Ruggiero, R. Rappuoli, and F. Bagnoli, “Helicobacter pylori CagA: from pathogenic mechanisms to its use as an anti-cancer vaccine,” Frontiers in Immunology, vol. 4, article 328, 2013. View at Publisher · View at Google Scholar
  8. M. Suzuki, H. Mimuro, K. Kiga et al., “Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation,” Cell Host & Microbe, vol. 5, no. 1, pp. 23–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. T. Franco, D. A. Israel, M. K. Washington et al., “Activation of β-catenin by carcinogenic Helicobacter pylori,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 30, pp. 10646–10651, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Wei, T. A. Nagy, A. Vilgelm et al., “Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells,” Gastroenterology, vol. 139, no. 4, pp. 1333–1343, 2010. View at Google Scholar
  11. X. Yong, B. Tang, B.-S. Li et al., “Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways,” Cell Communication and Signaling, vol. 13, article 30, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Hirata, S. Maeda, T. Ohmae et al., “Helicobacter pylori induces IκB kinase α nuclear translocation and chemokine production in gastric epithelial cells,” Infection and Immunity, vol. 74, no. 3, pp. 1452–1461, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. D. W. Kang, W. C. Hwang, M. H. Park et al., “Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells,” Oncogene, vol. 32, no. 30, pp. 3531–3542, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Suzuki, N. Murata-Kamiya, K. Yanagiya et al., “Mutual reinforcement of inflammation and carcinogenesis by the Helicobacter pylori CagA oncoprotein,” Scientific Reports, vol. 5, Article ID 10024, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. R. M. Delahay and M. Rugge, “Pathogenesis of Helicobacter pylori infection,” Helicobacter, vol. 17, no. 1, pp. 9–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Bagheri, F. Azadegan-Dehkordi, H. Shirzad, M. Rafieian-Kopaei, G. Rahimian, and A. Razavi, “The biological functions of IL-17 in different clinical expressions of Helicobacter pylori-infection,” Microbial Pathogenesis, vol. 81, pp. 33–38, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Sokolova, M. Borgmann, C. Rieke, K. Schweitzer, H.-J. Rothkötter, and M. Naumann, “Helicobacter pylori induces type 4 secretion system-dependent, but CagA-independent activation of IκBs and NF-κB/RelA at early time points,” International Journal of Medical Microbiology, vol. 303, no. 8, pp. 548–552, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Franceschi, A. Tortora, G. Gasbarrini, and A. Gasbarrini, “Helicobacter pylori and extragastric diseases,” Helicobacter, vol. 19, supplement 1, pp. 52–58, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Franceschi, N. Christodoulides, M. H. Kroll, and R. M. Genta, “Helicobacter pylori and idiopathic thrombocytopenic purpura,” Annals of Internal Medicine, vol. 140, no. 9, pp. 766–767, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Wong, E. Rayner-Hartley, and M. F. Byrne, “Extraintestinal manifestations of Helicobacter pylori: a concise review,” World Journal of Gastroenterology, vol. 20, no. 34, pp. 11950–11961, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Papagiannakis, C. Michalopoulos, F. Papalexi, D. Dalampoura, and M. D. Diamantidis, “The role of Helicobacter pylori infection in hematological disorders,” European Journal of Internal Medicine, vol. 24, no. 8, pp. 685–690, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. G. S. Tamer, I. Tengiz, E. Ercan, C. Duman, E. Alioglu, and U. O. Turk, “Helicobacter pylori seropositivity in patients with acute coronary syndromes,” Digestive Diseases and Sciences, vol. 54, no. 6, pp. 1253–1256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Weller, A. Charlett, N. L. Oxlade et al., “Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 3: predicted probability and gradients of severity of idiopathic parkinsonism based on H. pylori antibody profile,” Helicobacter, vol. 10, no. 4, pp. 288–297, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Kucukazman, B. Yavuz, M. Sacikara et al., “The relationship between updated Sydney system score and LDL cholesterol levels in patients infected with Helicobacter pylori,” Digestive Diseases and Sciences, vol. 54, no. 3, pp. 604–607, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. P. L. Lutsey, J. S. Pankow, A. G. Bertoni, M. Szklo, and A. R. Folsom, “Serological evidence of infections and Type 2 diabetes: the multiethnic study of atherosclerosis: original article: epidemiology,” Diabetic Medicine, vol. 26, no. 2, pp. 149–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. E. H. Hassan, S. S. Gerges, K. A. El-Atrebi, and H. T. El-Bassyouni, “The role of H. pylori infection in gall bladder cancer: clinicopathological study,” Tumor Biology, vol. 36, no. 9, pp. 7093–7098, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Tongtawee, S. Kaewpitoon, N. Kaewpitoon et al., “Helicobacter pylori associated gastritis increases risk of colorectal polyps: a hospital based-cross-sectional study in Nakhon Ratchasima Province, Northeastern Thailand,” Asian Pacific Journal of Cancer Prevention, vol. 17, no. 1, pp. 341–345, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Hirsch, N. Tegtmeyer, M. Rohde, M. Rowland, O. A. Oyarzabal, and S. Backert, “Live Helicobacter pylori in the root canal of endodontic-infected deciduous teeth,” Journal of Gastroenterology, vol. 47, no. 8, pp. 936–940, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. C. M. Kilmartin, “Dental implications of Helicobacter pylori,” Journal of Canadian Dental Association, vol. 68, no. 8, pp. 489–493, 2002. View at Google Scholar
  30. K. Piriyapong, A. Tangaroonsanti, V. Mahachai, and R.-K. Vilaichone, “Helicobacter pylori infection impacts on functional dyspepsia in Thailand,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 24, pp. 10887–10891, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Li, Y. Nie, W. Sha, and H. Su, “The link between psychosocial factors and functional dyspepsia: an epidemiological study,” Chinese Medical Journal, vol. 115, no. 7, pp. 1082–1084, 2002. View at Google Scholar · View at Scopus
  32. B. F. Filipović, T. Randjelovic, T. Ille et al., “Anxiety, personality traits and quality of life in functional dyspepsia-suffering patients,” European Journal of Internal Medicine, vol. 24, no. 1, pp. 83–86, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Frick, F. Åhs, J. Engman et al., “Serotonin synthesis and reuptake in social anxiety disorder a positron emission tomography study,” JAMA Psychiatry, vol. 72, no. 8, pp. 794–802, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. C. K. Y. Cheung, Y. Y. Lee, Y. Chan et al., “Decreased basal and postprandial plasma serotonin levels in patients with functional dyspepsia,” Clinical Gastroenterology and Hepatology, vol. 11, no. 9, pp. 1125–1129, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Toyoshima, T. Oshima, S. Nakajima et al., “Serotonin transporter gene polymorphism may be associated with functional dyspepsia in a Japanese population,” BMC Medical Genetics, vol. 12, article 88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Atkinson, S. Lockhart, P. J. Whorwell, B. Keevil, and L. A. Houghton, “Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome,” Gastroenterology, vol. 130, no. 1, pp. 34–43, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. G. P. Ahern, “5-HT and the immune system,” Current Opinion in Pharmacology, vol. 11, no. 1, pp. 29–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Haugen, R. Dammen, B. Svejda et al., “Differential signal pathway activation and 5-HT function: the role of gut enterochromaffin cells as oxygen sensors,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 303, no. 10, pp. G1164–G1173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. T. W. Stone and L. G. Darlington, “Endogenous kynurenines as targets for drug discovery and development,” Nature Reviews Drug Discovery, vol. 1, no. 8, pp. 609–620, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. O. A. Paoluzi, D. V. G. Blanco, R. Caruso, I. Monteleone, G. Monteleone, and F. Pallone, “Impairment of ghrelin synthesis in Helicobacter pylori-colonized stomach: new clues for the pathogenesis of H. pylori-related gastric inflammation,” World Journal of Gastroenterology, vol. 20, no. 3, pp. 639–646, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Suzuki and P. Moayyedi, “Helicobacter pylori infection in functional dyspepsia,” Nature Reviews Gastroenterology & Hepatology, vol. 10, no. 3, pp. 168–174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. J. Choi, N. Kim, H. Yoon et al., “Increase in plasma acyl ghrelin levels is associated with abatement of dyspepsia following Helicobacter pylori eradication,” Journal of Gastroenterology, vol. 51, no. 6, pp. 548–559, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Eren, O. Colak, S. Işiksoy, and A. Yavuz, “Effect of H. pylori infection on gastrin, ghrelin, motilin, and gastroesophageal reflux,” The Turkish Journal of Gastroenterology, vol. 26, no. 5, pp. 367–372, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Khosravi, S. W. Seow, A. A. Amoyo et al., “Helicobacter pylori infection can affect energy modulating hormones and body weight in germ free mice,” Scientific Reports, vol. 5, article 8731, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Shindo, S. Futagami, T. Hiratsuka et al., “Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease,” Digestion, vol. 79, no. 2, pp. 65–72, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. C. K. Cheung and J. C.-Y. Wu, “Role of ghrelin in the pathophysiology of gastrointestinal disease,” Gut and Liver, vol. 7, no. 5, pp. 505–512, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. O. A. Paoluzi, G. Del Vecchio Blanco, R. Caruso et al., “Helicobacter pylori infection associates with a mucosal downregulation of Ghrelin, negative regulator of Th1-cell responses,” Helicobacter, vol. 18, no. 6, pp. 406–412, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. B. L. Slomiany and A. Slomiany, “Role of ghrelin-induced phosphatidylinositol 3-kinase activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori,” Inflammopharmacology, vol. 22, no. 3, pp. 169–177, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. B. L. Slomiany and A. Slomiany, “Modulation of gastric mucosal inflammatory responses to Helicobacter pylori via ghrelin-induced protein kinase Cδ tyrosine phosphorylation,” Inflammopharmacology, vol. 22, no. 4, pp. 251–262, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. T. S. Steigedal, W. S. Prestvik, L.-K. M. Selvik et al., “Gastrin-induced proliferation involves MEK partner 1 (MP1),” In Vitro Cellular and Developmental Biology-Animal, vol. 49, no. 3, pp. 162–169, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Quattrone, B. Dewaele, A. Wozniak et al., “Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis,” The Journal of Pathology, vol. 228, no. 4, pp. 565–574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Zaki, P. E. Coudron, R. W. McCuen, L. Harrington, S. Chu, and M. L. Schubert, “H. pylori acutely inhibits gastric secretion by activating CGRP sensory neurons coupled to stimulation of somatostatin and inhibition of histamine secretion,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 304, no. 8, pp. G715–G722, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. T. L. Cover, “Role of Helicobacter pylori CagL in modulating gastrin expression,” Gut, vol. 61, no. 7, pp. 965–966, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Wiedemann, S. Hofbaur, N. Tegtmeyer et al., “Helicobacter pylori CagL dependent induction of gastrin expression via a novel αvβ5-integrin–integrin linked kinase signalling complex,” Gut, vol. 61, no. 7, pp. 986–996, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. M.-R. He, Y.-G. Song, and F.-C. Zhi, “Gastrointestinal hormone abnormalities and G and D cells in functional dyspepsia patients with gastric dysmotility,” World Journal of Gastroenterology, vol. 11, no. 3, pp. 443–446, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Van Oudenhove, J. Vandenberghe, B. Geeraerts et al., “Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation?” Gut, vol. 57, no. 12, pp. 1666–1673, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. S. O'Mahony, T. G. Dinan, P. W. Keeling, and A. S. B. Chua, “Central serotonergic and noradrenergic receptors in functional dyspepsia,” World Journal of Gastroenterology, vol. 12, no. 17, pp. 2681–2687, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. D. Chakroborty, C. Sarkar, R. B. Mitra, S. Banerjee, P. S. Dasgupta, and S. Basu, “Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis,” Clinical Cancer Research, vol. 10, no. 13, pp. 4349–4356, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Nishikawa, K. Amagase, and K. Takeuchi, “Effect of dopamine on the healing of acetic acid-induced gastric ulcers in rats,” Inflammopharmacology, vol. 15, no. 5, pp. 209–213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Yilmaz, C. B. Gul, M. Arabul, and M. A. Eren, “Helicobacter pylori: a role in schizophrenia?” Medical Science Monitor, vol. 14, no. 7, pp. HY13–HY16, 2008. View at Google Scholar · View at Scopus
  61. M. Giusti, M. R. Falivene, L. Foppiani, V. Savarino, and A. Costa, “Increased prevalence of Helicobacter pylori infection in females treated with dopaminergic drugs for hyperprolactinaemia,” Clinical Endocrinology, vol. 48, no. 3, pp. 373–374, 1998. View at Publisher · View at Google Scholar · View at Scopus
  62. C. Kirschbaum and D. H. Hellhammer, “Salivary cortisol in psychoneuroendocrine research: recent developments and applications,” Psychoneuroendocrinology, vol. 19, no. 4, pp. 313–333, 1994. View at Publisher · View at Google Scholar · View at Scopus
  63. U. Ehlert, U. M. Nater, and A. Böhmelt, “High and low unstimulated salivary cortisol levels correspond to different symptoms of functional gastrointestinal disorders,” Journal of Psychosomatic Research, vol. 59, no. 1, pp. 7–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. J. M. De la Roca-Chiapas, S. Solís-Ortiz, M. Fajardo-Araujo, M. Sosa, T. Córdova-Fraga, and A. Rosa-Zarate, “Stress profile, coping style, anxiety, depression, and gastric emptying as predictors of functional dyspepsia: a case-control study,” Journal of Psychosomatic Research, vol. 68, no. 1, pp. 73–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. B. Koşan, O. Yüksel, I. Üstün et al., “Role of endogenous cortisol on Helicobacter pylori colonization,” Clinical Biochemistry, vol. 41, no. 10-11, pp. 917–919, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Katagiri, S. Inoue, Y. Sato, H. Itoh, and M. Takeyama, “Comparison of the effects of proton pump inhibitors on human plasma adrenocorticotropic hormone and cortisol levels under the starved condition,” Biomedicine & Pharmacotherapy, vol. 60, no. 3, pp. 109–112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. S. L. Silva Lorena, M. J. De Oliveira Figueiredo, J. R. Souza Almeida, and M. A. Mesquita, “Autonomic function in patients with functional dyspepsia assessed by 24-hour heart rate variability,” Digestive Diseases and Sciences, vol. 47, no. 1, pp. 27–31, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. F. De Giorgi, G. Sarnelli, C. Cirillo et al., “Increased severity of dyspeptic symptoms related to mental stress is associated with sympathetic hyperactivity and enhanced endocrine response in patients with postprandial distress syndrome,” Neurogastroenterology and Motility, vol. 25, no. 1, pp. 31.e1–31.e3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Stasi, M. Bellini, F. Costa et al., “Neuroendocrine markers and psychological features in patients with irritable bowel syndrome,” International Journal of Colorectal Disease, vol. 28, no. 9, pp. 1203–1208, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Miwa, U. C. Ghoshal, K. M. Fock et al., “Asian consensus report on functional dyspepsia,” Journal of Gastroenterology and Hepatology (Australia), vol. 27, no. 4, pp. 626–641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. A. C. Ford, “Eradicating Helicobacter pylori in functional dyspepsia,” Gastroenterology, vol. 142, no. 7, pp. 1613–1614, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. L. Lan, J. Yu, Y.-L. Chen et al., “Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia,” World Journal of Gastroenterology, vol. 17, no. 27, pp. 3242–3247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. N. J. Talley, G. Holtmann, and M. M. Walker, “Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology,” Journal of Gastroenterology, vol. 50, no. 6, pp. 601–613, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. L. E. Mazzoleni, G. B. Sander, C. F. D. M. Francesconi et al., “Helicobacter pylori eradication in functional dyspepsia: HEROES trial,” Archives of Internal Medicine, vol. 171, no. 21, pp. 1929–1936, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. G. Zhang, J. Zou, F. Liu et al., “The efficacy of moxifloxacin-based triple therapy in treatment of Helicobacter pylori infection: a systematic review and meta-analysis of randomized clinical trials,” Brazilian Journal of Medical and Biological Research, vol. 46, no. 7, pp. 607–613, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. C. S. O. Eun, B. K. W. Kim, D. S. O. Han et al., “Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods,” Helicobacter, vol. 19, no. 6, pp. 407–416, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. K. Lertpiriyapong, M. T. Whary, S. Muthupalani et al., “Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis,” Gut, vol. 63, no. 1, pp. 54–63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. A. F. Andersson, M. Lindberg, H. Jakobsson, F. Bäckhed, P. Nyrén, and L. Engstrand, “Comparative analysis of human gut microbiota by barcoded pyrosequencing,” PLoS ONE, vol. 3, no. 7, Article ID e2836, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. C. Kiank, Y. Taché, and M. Larauche, “Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors,” Brain, Behavior, and Immunity, vol. 24, no. 1, pp. 41–48, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. G. M. Mawe and J. M. Hoffman, “Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets,” Nature Reviews Gastroenterology and Hepatology, vol. 10, no. 8, pp. 473–486, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. Y.-J. Fang, J.-M. Liou, C.-C. Chen et al., “Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria,” Gut, vol. 64, no. 10, pp. 1517–1528, 2015. View at Publisher · View at Google Scholar · View at Scopus